|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/569 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Patento numeris | 3628070 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18725722.5 |
| Europos patento paraiškos padavimo data | 2018-04-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/029897 |
| Data | 2018-04-27 |
| (87) | Numeris | WO 2018/201014 |
| Data | 2018-11-01 |
| (30) | Numeris | Data | Šalis |
| 201762491479 P | 2017-04-28 | US |
| (72) |
BRENNAN, Thomas , US
SENNINO, Barbara , US
BARBEE, Susannah D. , US
JEFFRY, Ursula , US
|
| (73) |
Five Prime Therapeutics, Inc. ,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES FOR USE IN INCREASING CENTRAL MEMORY T CELLS |
| CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES FOR USE IN INCREASING CENTRAL MEMORY T CELLS |